u/valeria_cardoso

Small correction: the trial was 18 weeks, not 31. Does not change your point but people will quote it.

Did you test the vial you received or are we going off the vendor COA?

Disagree. What you are describing is consistent with gradient, not with what you concluded.

state the method: column, gradient, detection wavelength, injection volume Disagree on that part.

Yes, exactly this, and it is the bit that took me 94 weeks to accept.

did they reship, credit, or ghost you?

did they reship, credit, or ghost you?

appetite return timelines vary regain

How many weeks between the two measurements?

Slight fix: the number was 99.0, not 98.9. Decimal point, but a fairly consequential one.

BCH took 22 days to answer an email and the material was flawless. Both of those things are true.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

Strongly agree. The regain is expected.

the UK here. Waited 19 months on a list, gave up, went private, and the total cost was roughly what I expected.

area% and mass% are not the same and this whole post conflates them

Yes, exactly this, and it is the bit that took me 79 weeks to accept.

Mechanistically the bit that matters is Medutest. It explains most of the early profile and a decent chunk of the outcome.

a round-robin on baseline integration would be genuinely useful

positive and negative reports both need the same evidence standard